Latest Europe News

Dimerix has received a US$10 million upfront payment from Everest Medicines under a regional licensing deal for DMX-200 targeting FSGS in Greater China, South Korea and Southeast Asia. This deal marks Dimerix’s fifth commercial partnership for DMX-200, collectively worth up to A$1.9 billion in milestones and royalties.

Servcorp Limited delivered a record FY26 with a 24% rise in underlying NPBIT to $87 million, boosted dividends by 14%, and outlined a cautious yet optimistic FY27 growth strategy.

Medical Developments International (ASX:MVP) reported a 9% revenue increase to $42.6 million and a 566% jump in net profit to $0.6 million for FY26, driven by robust growth in its Pain Management segment and expanded paediatric approvals in Europe.

Telix Pharmaceuticals returned to profit in H1 2026, driven by strong U.S. sales of Illuccix and Gozellix, a $40 million upfront from Regeneron collaboration, and expanded R&D investment.

Goodman Group delivered a robust FY2026 result, with statutory profit soaring 66.7% to $2.78 billion and operating profit rising 15.7%. The industrial and logistics property giant maintained steady dividends amid portfolio expansion and increased gearing.

Skellerup Holdings delivered a tenth consecutive year of EBIT growth with a 14% rise to NZD 89.3 million and expanded its climate initiatives, reporting a 24% jump in net profit to NZD 67.7 million.

BLIS Technologies has kicked off FY27 with a 42% revenue increase and a return to EBITDA profitability, driven by strong B2B growth in Asia Pacific and China.

Atomo Diagnostics has appointed Dr Cheri Walker as interim CEO, replacing founder John Kelly who steps down after 15 years. The leadership change aligns with the company's shift towards commercial growth in the US and Europe.

Credit Clear appoints Joshua Reid as Managing Director and interim CEO of ARMA Group Holdings, signaling a leadership shift aligned with its growth ambitions across Australia and international markets.

European Lithium and Critical Metals Corp have amended their merger terms to replace a fixed share exchange ratio with a floating ratio tied to Critical Metals' NASDAQ share price, potentially increasing shareholder value amid ongoing merger progress.

Schaffer Corporation reported a modest 8.6% decline in net profit for FY26 to $22.2 million, with a rebound in Automotive Leather offset by a loss at Delta and strong gains from its South Connect Jandakot property development.

Entropy Neurodynamics has partnered with BioCina to establish GMP manufacturing for its intravenous psilocin formulation TRP-8803, a critical step toward late-stage clinical trials and commercialisation.